UiPath - PATH Stock Price Target and Predictions

Target and Analyst Ratings
Price Target History
Upgrades and Downgrades
News Sentiment
About
FAQ

Consensus Rating: Moderate Buy
Consensus Price Target: $27.41
Forecasted Upside: 44.01%
Number of Analysts: 18
Breakdown:
0 Sell Ratings
9 Hold Ratings
9 Buy Ratings
0 Strong Buy Ratings

^$19.04 As of 04/18/2024 01:00 AM ET

▼ -0.09 (-0.47%)

1 month | 3 months | 12 months

Get New UiPath Analyst Ratings Delivered To Your Inbox

Sign-up to receive the latest news and ratings for PATH and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for PATH

^$27.41

▲ +44.01% Upside Potential

This price target is based on 18 analysts offering 12 month price targets for UiPath in the last 3 months. The average price target is $27.41, with a high forecast of $32.00 and a low forecast of $23.00. The average price target represents a 44.01% upside from the last price of $19.04.

Current Consensus is Moderate Buy

The current consensus among 18 contributing investment analysts is to moderate buy stock in UiPath. This Moderate Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

0 strong buy ratings
9 buy ratings
9 hold ratings
0 sell ratings

Ratings as of

10/26/2022

0 strong buy ratings
9 buy ratings
9 hold ratings
0 sell ratings

Ratings as of

1/24/2023

0 strong buy ratings
9 buy ratings
9 hold ratings
0 sell ratings

Ratings as of

4/24/2023

0 strong buy ratings
9 buy ratings
9 hold ratings
0 sell ratings

Ratings as of

7/23/2023

0 strong buy ratings
9 buy ratings
9 hold ratings
0 sell ratings

Ratings as of

10/21/2023

0 strong buy ratings
9 buy ratings
9 hold ratings
0 sell ratings

Ratings as of

1/19/2024

0 strong buy ratings
9 buy ratings
9 hold ratings
0 sell ratings

Ratings as of

3/19/2024

0 strong buy ratings
9 buy ratings
9 hold ratings
0 sell ratings

Ratings as of

4/18/2024

Latest Recommendations

Show Most Recent Rating from Each Ratings Firm Show All Ratings

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
4/8/2024	KeyCorp	Initiated Coverage	Overweight	$27.00	Low
4/1/2024	Royal Bank of Canada	Reiterated Rating	Sector Perform ➝ Sector Perform	$29.00	Low
3/20/2024	Truist Financial	Reiterated Rating	Buy ➝ Buy	$32.00	Low
3/20/2024	Royal Bank of Canada	Reiterated Rating	Sector Perform ➝ Sector Perform	$29.00	Low
3/20/2024	Needham & Company LLC	Reiterated Rating	Buy ➝ Buy	$30.00	Low
3/15/2024	Barclays	Boost Target	Equal Weight ➝ Equal Weight	$23.00 ➝ $25.00	Low
3/15/2024	Canaccord Genuity Group	Boost Target	Buy ➝ Buy	$27.00 ➝ $30.00	N/A
3/14/2024	Bank of America	Boost Target	Buy ➝ Buy	$26.00 ➝ $30.00	N/A
3/14/2024	Wells Fargo & Company	Boost Target	Equal Weight ➝ Equal Weight	$24.00 ➝ $25.00	N/A
3/14/2024	DA Davidson	Boost Target	Neutral ➝ Neutral	$20.00 ➝ $24.00	N/A
3/14/2024	Mizuho	Boost Target	Neutral ➝ Neutral	$22.00 ➝ $25.00	Low
3/14/2024	Scotiabank	Boost Target	Sector Perform ➝ Sector Perform	$29.00 ➝ $30.00	Low
3/14/2024	Royal Bank of Canada	Boost Target	Sector Perform ➝ Sector Perform	$27.00 ➝ $29.00	Low
3/14/2024	BMO Capital Markets	Boost Target	Market Perform ➝ Market Perform	$24.00 ➝ $28.00	Low
3/14/2024	Evercore ISI	Boost Target	In-Line ➝ In-Line	$24.00 ➝ $27.00	Low
3/14/2024	Morgan Stanley	Boost Target	Equal Weight ➝ Equal Weight	$17.00 ➝ $25.00	Low
3/14/2024	TD Cowen	Boost Target	Outperform ➝ Outperform	$25.00 ➝ $28.00	Low
3/14/2024	JPMorgan Chase & Co.	Upgrade	Neutral ➝ Overweight	$22.00 ➝ $28.00	Low
3/14/2024	Needham & Company LLC	Boost Target	Buy ➝ Buy	$25.00 ➝ $30.00	Low
2/21/2024	Scotiabank	Initiated Coverage	Sector Perform		Low
1/12/2024	Barclays	Boost Target	Equal Weight ➝ Equal Weight	$21.00 ➝ $23.00	Low
1/2/2024	William Blair	Initiated Coverage	Outperform		Low
12/4/2023	Canaccord Genuity Group	Boost Target	Buy ➝ Buy	$21.00 ➝ $24.00	Low
12/1/2023	JPMorgan Chase & Co.	Boost Target	Neutral ➝ Neutral	$19.00 ➝ $22.00	Low
12/1/2023	Royal Bank of Canada	Boost Target	Sector Perform ➝ Sector Perform	$19.00 ➝ $24.00	Low
12/1/2023	BMO Capital Markets	Boost Target	Market Perform ➝ Market Perform	$19.00 ➝ $24.00	Low
12/1/2023	Morgan Stanley	Boost Target	Equal Weight ➝ Equal Weight	$16.00 ➝ $17.00	Low
12/1/2023	Wells Fargo & Company	Boost Target	Equal Weight ➝ Equal Weight	$18.00 ➝ $20.00	Low
12/1/2023	Needham & Company LLC	Boost Target	Buy ➝ Buy	$20.00 ➝ $25.00	Low
12/1/2023	Mizuho	Boost Target	Neutral ➝ Neutral	$18.00 ➝ $22.00	Low
10/11/2023	Needham & Company LLC	Reiterated Rating	Buy ➝ Buy	$20.00	Low
9/28/2023	Royal Bank of Canada	Reiterated Rating	Sector Perform ➝ Sector Perform	$19.00	Low
9/7/2023	Canaccord Genuity Group	Boost Target	Buy ➝ Buy	$19.00 ➝ $21.00	Low
9/7/2023	Macquarie	Boost Target	Outperform ➝ Outperform	$22.00 ➝ $23.00	Low
9/7/2023	Needham & Company LLC	Reiterated Rating	Buy ➝ Buy	$20.00	Low
9/7/2023	BMO Capital Markets	Boost Target	Market Perform ➝ Market Perform	$18.00 ➝ $19.00	Low
9/7/2023	DA Davidson	Boost Target	Neutral ➝ Neutral	$16.00 ➝ $17.00	Low
9/7/2023	Royal Bank of Canada	Boost Target	Sector Perform ➝ Sector Perform	$18.00 ➝ $19.00	Low
9/7/2023	Mizuho	Boost Target	Neutral ➝ Neutral	$16.00 ➝ $18.00	Low
9/7/2023	Bank of America	Boost Target		$20.00 ➝ $22.00	Low
9/7/2023	Barclays	Boost Target		$16.00 ➝ $18.00	Low
6/9/2023	Wells Fargo & Company	Downgrade	Overweight ➝ Equal Weight	$20.00	Low
5/25/2023	BMO Capital Markets	Lower Target		$20.00 ➝ $18.00	Low
5/25/2023	Barclays	Lower Target		$17.00 ➝ $16.00	Low
4/20/2023	DA Davidson	Initiated Coverage	Neutral	$16.00	Low
4/3/2023	TD Cowen	Boost Target	Outperform	$20.00 ➝ $22.00	Low
3/29/2023	Royal Bank of Canada	Boost Target	Sector Perform	$17.00 ➝ $18.00	Low
3/17/2023	Credit Suisse Group	Reiterated Rating	Outperform	$27.50	Low
3/17/2023	BMO Capital Markets	Boost Target		$16.00 ➝ $20.00	Low
3/16/2023	Wells Fargo & Company	Boost Target	Overweight	$18.00 ➝ $20.00	Low
3/16/2023	Needham & Company LLC	Reiterated Rating	Buy	$20.00	Low
3/16/2023	Morgan Stanley	Boost Target	Equal Weight	$15.00 ➝ $16.00	Low
3/16/2023	JPMorgan Chase & Co.	Boost Target	Neutral	$16.00 ➝ $18.00	Low
3/16/2023	Royal Bank of Canada	Boost Target		$15.00 ➝ $17.00	Low
3/16/2023	Mizuho	Boost Target		$15.00 ➝ $16.00	Low
3/16/2023	Canaccord Genuity Group	Upgrade	Hold ➝ Buy	$14.50 ➝ $19.00	Low
3/16/2023	Barclays	Boost Target	Equal Weight	$13.00 ➝ $17.00	Low
3/13/2023	Royal Bank of Canada	Reiterated Rating	Sector Perform	$15.00	Low
1/10/2023	Barclays	Lower Target	Equal Weight	$15.00 ➝ $13.00	Low
12/2/2022	Evercore ISI	Lower Target		$17.00	Low
12/2/2022	JPMorgan Chase & Co.	Lower Target	Neutral	$18.00 ➝ $16.00	Low
12/2/2022	Wells Fargo & Company	Boost Target	Overweight	$16.00 ➝ $18.00	Low
12/2/2022	Truist Financial	Lower Target	Buy	$25.00 ➝ $20.00	Low
12/2/2022	Mizuho	Boost Target		$14.00 ➝ $15.00	Low
11/28/2022	Royal Bank of Canada	Lower Target	Sector Perform	$16.00 ➝ $15.00	Low
11/16/2022	Credit Suisse Group	Lower Target	Outperform	$30.00 ➝ $27.50	Low
11/3/2022	Oppenheimer	Downgrade	Outperform ➝ Market Perform		Low
10/18/2022	Barclays	Downgrade	Overweight ➝ Equal Weight	$17.00 ➝ $15.00	N/A
9/30/2022	Canaccord Genuity Group	Lower Target	Hold	$15.00 ➝ $14.00	Low
9/30/2022	Wells Fargo & Company	Lower Target	Overweight	$22.00 ➝ $16.00	Low
9/28/2022	Bank of America	Lower Target		$20.00 ➝ $18.00	Low
9/28/2022	Credit Suisse Group	Lower Target	Outperform	$37.50 ➝ $30.00	Low
9/28/2022	Barclays	Lower Target	Overweight	$18.00 ➝ $17.00	Low
9/7/2022	Canaccord Genuity Group	Reiterated Rating	Buy ➝ Hold	$25.00 ➝ $15.00	Low
9/7/2022	Canaccord Genuity Group	Downgrade	Buy ➝ Hold	$25.00 ➝ $15.00	Low
9/7/2022	Cowen	Lower Target	Outperform	$27.00 ➝ $20.00	Low
9/7/2022	Truist Financial	Lower Target	Buy	$45.00 ➝ $25.00	Low
9/7/2022	BMO Capital Markets	Lower Target		$21.00 ➝ $15.00	Low
9/7/2022	Royal Bank of Canada	Lower Target		$22.00 ➝ $18.00	Low
9/7/2022	Needham & Company LLC	Lower Target	Buy	$40.00 ➝ $20.00	Low
9/7/2022	Cowen	Lower Target		$27.00 ➝ $20.00	Low
9/7/2022	Wells Fargo & Company	Lower Target	Overweight	$30.00 ➝ $22.00	Low
9/7/2022	Credit Suisse Group	Lower Target	Outperform	$45.00 ➝ $37.50	Low
9/7/2022	Mizuho	Downgrade	Buy ➝ Neutral	$40.00 ➝ $14.00	Low
9/7/2022	Morgan Stanley	Downgrade	Overweight ➝ Equal Weight	$32.00 ➝ $15.00	Low
7/7/2022	Canaccord Genuity Group	Reiterated Rating	Buy	$25.00	N/A
6/2/2022	BMO Capital Markets	Lower Target		$29.00 ➝ $21.00	Low
6/2/2022	Truist Financial	Lower Target		$55.00 ➝ $45.00	High
6/2/2022	Evercore ISI	Lower Target		$28.00 ➝ $23.00	High
6/2/2022	Credit Suisse Group	Lower Target		$57.50 ➝ $45.00	High
6/2/2022	Oppenheimer	Lower Target	Buy	$35.00 ➝ $23.00	High
5/31/2022	Royal Bank of Canada	Lower Target		$32.00 ➝ $27.00	High
5/27/2022	Cowen	Lower Target		$43.00 ➝ $27.00	Medium
5/20/2022	Barclays	Lower Target		$36.00 ➝ $25.00	Medium
5/18/2022	Wells Fargo & Company	Lower Target		$35.00 ➝ $30.00	Medium
4/25/2022	KeyCorp	Lower Target	Overweight	$34.00 ➝ $23.00	High
3/31/2022	Morgan Stanley	Lower Target	Overweight	$74.00 ➝ $41.00	High
3/31/2022	Canaccord Genuity Group	Lower Target	Hold	$55.00 ➝ $30.00	High
3/31/2022	Truist Financial	Lower Target	Buy	$75.00 ➝ $55.00	High
3/31/2022	Needham & Company LLC	Lower Target	Buy	$85.00 ➝ $40.00	High
3/31/2022	Cowen	Lower Target		$72.00 ➝ $43.00	High
3/31/2022	BMO Capital Markets	Lower Target	Market Perform	$52.00 ➝ $29.00	High
3/31/2022	Mizuho	Lower Target	Buy	$70.00 ➝ $40.00	High
3/31/2022	Credit Suisse Group	Lower Target	Outperform	$75.00 ➝ $57.50	High
3/31/2022	Oppenheimer	Lower Target	Outperform	$56.00 ➝ $35.00	High
3/31/2022	Wells Fargo & Company	Lower Target	Overweight	$45.00 ➝ $35.00	High
3/29/2022	Evercore ISI	Lower Target		$57.00 ➝ $36.00	High
3/28/2022	Royal Bank of Canada	Lower Target	Sector Perform	$47.00 ➝ $37.00	High
3/15/2022	Wells Fargo & Company	Lower Target	Overweight	$60.00 ➝ $45.00	Low
1/25/2022	Macquarie	Upgrade	Neutral ➝ Outperform		Low
1/20/2022	Oppenheimer	Upgrade	Market Perform ➝ Outperform	$56.00	High
1/12/2022	Barclays	Lower Target		$61.00 ➝ $57.00	High
1/6/2022	Wells Fargo & Company	Upgrade	Equal Weight ➝ Overweight	$60.00	High
12/9/2021	Truist Financial	Lower Target	Buy ➝ Buy	$82.00 ➝ $75.00	Low
12/9/2021	KeyCorp	Lower Target	Overweight ➝ Overweight	$86.00 ➝ $69.00	Low
12/9/2021	Barclays	Lower Target	Overweight	$71.00 ➝ $61.00	Low
12/9/2021	Wells Fargo & Company	Lower Target	Equal Weight ➝ Equal Weight	$65.00 ➝ $50.00	Low
12/9/2021	Macquarie	Reiterated Rating	Neutral	$71.00 ➝ $55.00	Medium
12/9/2021	Berenberg Bank	Upgrade	Hold ➝ Buy	$64.00	Low
12/3/2021	Morgan Stanley	Upgrade	Equal Weight ➝ Overweight	$74.00	High
12/1/2021	BMO Capital Markets	Lower Target	Positive ➝ Market Perform	$70.00 ➝ $57.00	High
11/16/2021	Credit Suisse Group	Initiated Coverage	Outperform	$75.00	High
10/8/2021	Cowen	Lower Target	Outperform	$80.00 ➝ $72.00	Medium
10/7/2021	Royal Bank of Canada	Lower Target	Sector Perform	$74.00 ➝ $65.00	Low
10/6/2021	Needham & Company LLC	Reiterated Rating	Buy	$85.00	Low
9/17/2021	Barclays	Upgrade	Equal Weight ➝ Overweight	$70.00 ➝ $71.00	High
9/8/2021	Barclays	Lower Target	Equal Weight	$73.00 ➝ $70.00	Low
9/8/2021	BMO Capital Markets	Lower Target	Market Perform	$85.00 ➝ $70.00	High
9/8/2021	Morgan Stanley	Boost Target	Equal Weight	$72.00 ➝ $74.00	High
9/8/2021	Cowen	Lower Target	Outperform	$84.00 ➝ $80.00	High
9/8/2021	Wells Fargo & Company	Lower Target	Equal Weight	$75.00 ➝ $65.00	High
9/8/2021	Oppenheimer	Reiterated Rating	Hold		High
7/12/2021	Summit Redstone	Initiated Coverage	Sell	$40.00	Low
7/12/2021	Summit Insights	Initiated Coverage	Sell	$40.00	Medium
6/10/2021	Evercore ISI	Reiterated Rating	Hold	$72.00	High
6/9/2021	BMO Capital Markets	Boost Target	Market Perform	$80.00 ➝ $85.00	High
6/9/2021	Truist Financial	Boost Target	Buy	$80.00 ➝ $82.00	Medium
6/9/2021	KeyCorp	Boost Target	Overweight	$82.00 ➝ $86.00	High
6/9/2021	Morgan Stanley	Boost Target	Equal Weight	$70.00 ➝ $72.00	High
6/9/2021	Needham & Company LLC	Reiterated Rating	Buy	$85.00	High
6/9/2021	Barclays	Boost Target	Equal Weight	$71.00 ➝ $73.00	High
5/24/2021	Oppenheimer	Initiated Coverage	Market Perform		High
5/19/2021	Berenberg Bank	Initiated Coverage	Hold	$64.00	Low
5/17/2021	Truist Financial	Initiated Coverage	Buy	$80.00	N/A
5/17/2021	Macquarie	Initiated Coverage	Neutral	$69.00	N/A
5/17/2021	Wolfe Research	Initiated Coverage	Peer Perform	$70.00	N/A
5/17/2021	DA Davidson	Initiated Coverage	Buy	$85.00	N/A
5/17/2021	Wells Fargo & Company	Initiated Coverage	Equal Weight	$75.00	N/A
5/17/2021	Mizuho	Initiated Coverage	Buy	$77.00	N/A
5/17/2021	Needham & Company LLC	Initiated Coverage	Buy	$85.00	N/A
5/17/2021	Cowen	Initiated Coverage	Outperform	$82.00	N/A
5/17/2021	Morgan Stanley	Initiated Coverage	Equal Weight	$70.00	N/A
5/17/2021	Royal Bank of Canada	Initiated Coverage	Sector Perform	$74.00	N/A
5/17/2021	Bank of America	Initiated Coverage	Buy	$85.00	N/A
5/17/2021	JPMorgan Chase & Co.	Initiated Coverage	Neutral	$68.00	N/A
5/17/2021	BMO Capital Markets	Initiated Coverage	Market Perform	$80.00	N/A
5/17/2021	Barclays	Initiated Coverage	Equal Weight	$71.00	N/A
5/17/2021	KeyCorp	Initiated Coverage	Overweight	$82.00	N/A
5/17/2021	Evercore ISI	Initiated Coverage	In-Line	$72.00	N/A
5/17/2021	Oppenheimer	Reiterated Rating	Market Perform		N/A
5/13/2021	Berenberg Bank	Initiated Coverage	Hold	$64.00	N/A

(Data available from 4/18/2019 forward)

News Sentiment Rating

0.76 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

33 very positive mentions
38 positive mentions
4 negative mentions
1 very negative mentions

Mentions as of

9/21/2023

21 very positive mentions
31 positive mentions
1 negative mentions
1 very negative mentions

Mentions as of

10/21/2023

11 very positive mentions
17 positive mentions
2 negative mentions
0 very negative mentions

Mentions as of

11/20/2023

38 very positive mentions
37 positive mentions
0 negative mentions
1 very negative mentions

Mentions as of

12/20/2023

19 very positive mentions
21 positive mentions
1 negative mentions
2 very negative mentions

Mentions as of

1/19/2024

30 very positive mentions
33 positive mentions
1 negative mentions
0 very negative mentions

Mentions as of

2/18/2024

50 very positive mentions
51 positive mentions
7 negative mentions
0 very negative mentions

Mentions as of

3/19/2024

59 very positive mentions
46 positive mentions
6 negative mentions
0 very negative mentions

Mentions as of

4/18/2024

Current Sentiment

Recent Stories by Sentiment

UiPath Inc. provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, and Japan. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization. Its platform combines artificial intelligence with desktop recording, back-end mining of both human activity and system logs, and intuitive visualization tools, which enables users to discover, analyze, and identify processes to automate in a centralized portal; offers low-code development environments that allows users in an organization to create attended and unattended automations without any prior knowledge of coding; deploys robots in highly immersive attended experiences or in standalone, unattended modes behind the scenes, and can leverage native connectors built for commonly used line-of-business applications; offers centralized tools designed to manage, test, and deploy automations and ML models across the enterprise; allows customers to manage long running processes that orchestrate work between robots and humans; and enable users to track, measure, and forecast the performance of automation in their enterprise and help businesses ensure compliance with business standards. In addition, the company provides maintenance and support for its software, as well as professional services, such as training and implementation services to facilitate the adoption of its platform. It serves banking, healthcare, financial services, and government entities. UiPath Inc. has collaboration with Deloitte to introduce Turnkey automation offering for growth companies. The company was founded in 2005 and is headquartered in New York, New York.

Today's Range

Now: $19.04

$18.93

$19.40

50 Day Range

MA: $23.07

$19.12

$26.89

52 Week Range

Now: $19.04

$12.38

$27.87

Volume

4,722,430 shs

Average Volume

8,959,758 shs

Market Capitalization

$10.83 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.96

Frequently Asked Questions

What sell-side analysts currently cover shares of UiPath?: The following Wall Street sell-side analysts have issued research reports on UiPath in the last twelve months: Bank of America Co., Barclays PLC, BMO Capital Markets, Canaccord Genuity Group Inc., DA Davidson, Evercore ISI, JPMorgan Chase & Co., KeyCorp, Macquarie, Mizuho, Morgan Stanley, Needham & Company LLC, Royal Bank of Canada, Scotiabank, TD Cowen, Truist Financial Co., Wells Fargo & Company, and William Blair.
View the latest analyst ratings for PATH.
What is the current price target for UiPath?: 17 Wall Street analysts have set twelve-month price targets for UiPath in the last year. Their average twelve-month price target is $27.41, suggesting a possible upside of 44.0%. Truist Financial Co. has the highest price target set, predicting PATH will reach $32.00 in the next twelve months. Macquarie has the lowest price target set, forecasting a price of $23.00 for UiPath in the next year.
View the latest price targets for PATH.
What is the current consensus analyst rating for UiPath?: UiPath currently has 9 hold ratings and 9 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for PATH.
What other companies compete with UiPath?: Other companies that are similar to UiPath include Procore Technologies, DocuSign, Elastic, Gen Digital and Confluent. Learn More about companies similar to UiPath.
How do I contact UiPath's investor relations team?: UiPath's physical mailing address is 7 Great Valley Pkwy Ste 300, MALVERN, PA 19355-1425, United States. The healthcare company's listed phone number is 844-432-0455 and its investor relations email address is [email protected]. The official website for UiPath is www.uipath.com. Learn More about contacing UiPath investor relations.

UiPath - PATH Stock Price Target and Predictions

Analyst Price Target for PATH

Current Consensus is Moderate Buy

Past Monthly Recommendations

Latest Recommendations

News Sentiment Rating

0.76 (Buy)

News Sentiment Over Time

Current Sentiment

Recent Stories by Sentiment

Very Negative

Negative

Positive

Very Positive

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Frequently Asked Questions

What sell-side analysts currently cover shares of UiPath?

What is the current price target for UiPath?

What is the current consensus analyst rating for UiPath?

What other companies compete with UiPath?

How do I contact UiPath's investor relations team?